Acute Lymphoblastic Leukemia (ALL) research hub

International Study for Treatment of High Risk Childhood Relapsed ALL 2010

This study looks at new ways to treat children and teenagers with a type of blood cancer called acute lymphoblastic leukemia (ALL) that has come back. It investigates a new drug called Bortezomib to see if it can help improve treatment success for those with high-risk relapsed ALL.